FullText URL | fulltext20240226-04.pdf |
---|---|
Author | Kuribayashi, Tadahiro| Ohashi, Kadoaki| Nishii, Kazuya| Ninomiya, Kiichiro| Tsubata, Yukari| Ishikawa, Nobuhisa| Kodani, Masahiro| Kanaji, Nobuhiro| Yamasaki, Masahiro| Fujitaka, Kazunori| Kuyama, Shoichi| Takigawa, Nagio| Fujimoto, Nobukazu| Kubota, Tetsuya| Inoue, Masaaki| Fujiwara, Keiichi| Harita, Shingo| Takata, Ichiro| Takada, Kenji| Okawa, Sachi| Kiura, Katsuyuki| Hotta, Katsuyuki| |
Keywords | EGFR EGFR-TKI Lung cancer Immune checkpoint inhibitors Performance status |
Note | The version of record of this article, first published in Journal of Cancer Research and Clinical Oncology, is available online at Publisher’s website: http://dx.doi.org/10.1007/s00432-024-05618-4| |
Published Date | 2024-02-12 |
Publication Title | Journal of Cancer Research and Clinical Oncology |
Volume | volume150 |
Issue | issue2 |
Publisher | Springer Science and Business Media LLC |
Start Page | 89 |
ISSN | 1432-1335 |
Content Type | Journal Article |
language | English |
OAI-PMH Set | 岡山大学 |
Copyright Holders | © The Author(s) 2024 |
File Version | publisher |
PubMed ID | 38347279 |
DOI | 10.1007/s00432-024-05618-4 |
Web of Science KeyUT | 001160773600002 |
Related Url | isVersionOf https://doi.org/10.1007/s00432-024-05618-4 |